Sequana Medical alfapump® System Highlighted at SIR EDGE 2025 Conference, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Ghent, Belgium – 14 October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA (the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announced that the alfapump System was highlighted in a presentation at the Society of Interventional Radiology’s SIR EDGE 2025 conference in San Diego. The presentation titled “Not the Alpha Male, the Alfapump!” showcased the clinical impact and innovative approach of the alfapump technology.
Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage”
Transparency Notifications from ShareholdersTransparency Notifications from Shareholders
Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024
Transparency Notifications from ShareholdersPRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST
Sequana Medical announces 2023 Full Year Results and 2024 OutlookPRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 March 2024, 08:00 a.m. CET
Sequana Medical announces H1 2023 results and provides business updatePRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION14 September 2023, 07:00 CEST
